Innoviva, Inc.
INVA
$20.92
$0.040.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 45.53% | 80.82% | 63.34% | 61.38% | 52.96% |
| Total Other Revenue | -0.26% | 0.30% | 1.21% | 9.59% | 4.04% |
| Total Revenue | 12.02% | 18.70% | 15.54% | 21.46% | 13.80% |
| Cost of Revenue | -10.21% | -34.07% | -49.64% | -4.15% | -10.34% |
| Gross Profit | 17.71% | 37.01% | 44.38% | 29.60% | 22.22% |
| SG&A Expenses | -1.46% | 3.56% | 17.77% | 31.66% | 35.87% |
| Depreciation & Amortization | 0.55% | 6.22% | 18.90% | 33.90% | 80.57% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.68% | -0.84% | -2.82% | -0.36% | 4.05% |
| Operating Income | 18.39% | 48.01% | 43.95% | 55.66% | 28.10% |
| Income Before Tax | -57.15% | -123.39% | -80.74% | 8.34% | -43.06% |
| Income Tax Expenses | 255.20% | -19.73% | -2.64% | -49.25% | -89.41% |
| Earnings from Continuing Operations | -73.42% | -132.93% | -86.98% | 29.50% | -26.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -73.42% | -132.93% | -86.98% | 29.50% | -37.68% |
| EBIT | 18.39% | 48.01% | 43.95% | 55.66% | 28.10% |
| EBITDA | 15.76% | 41.11% | 40.14% | 52.46% | 33.93% |
| EPS Basic | -72.73% | -133.73% | -86.70% | 23.55% | -32.98% |
| Normalized Basic EPS | 26.04% | 58.76% | 55.18% | 72.92% | -6.39% |
| EPS Diluted | -79.99% | -144.74% | -90.46% | 55.69% | -26.90% |
| Normalized Diluted EPS | 29.12% | 84.31% | 69.91% | 71.95% | -5.23% |
| Average Basic Shares Outstanding | -1.42% | -2.63% | -4.16% | -5.88% | -6.66% |
| Average Diluted Shares Outstanding | -7.51% | -15.19% | -9.87% | -5.17% | -0.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |